Clinical Trials Sponsored by Instituto Nacional de Cancerologia, Columbia

Total 2866 results

Institut de Cancérologie de Lorraine

Completed

HCC Response Assessment by MRI After SBRT

Carcinoma, Hepatocellular
Institut de Cancérologie de Lorraine

Recruiting

Psycho-social Determinant for Sport Practised During Cancer (PERTINENCE)

Cancer | Physical Activity

France
Institut de Cancérologie de Lorraine

Completed

Artificial Intelligence to Search for Abnormalities in Ambulatory Cancer Patients (IASAAC)

Solid Tumor

France
Institut de Cancérologie de Lorraine

Active, not recruiting

Neoadjuvant mFolfirinox With or Without Preoperative Concomitant Chemoradiotherapy in Patients With Borderline Resectable Pancreatic Carcinoma (PANDAS-PRODIGE 44)

Pancreatic Carcinoma

France
Institut de Cancérologie de Lorraine

Completed

SexoMBC2 Non Interventional Study (SexoMBC2)

Quality of Life | Breast Cancer | Sexual Behavior

France
Institut de Cancérologie de Lorraine

Completed

Fluorescence for Sentinel Lymph Node Identification in Cancer Surgery (GASVERT)

Head and Neck Cancer | Breast Carcinoma | Cervix Cancer | Melanoma (Skin) | Ovary Cancer | Rectum Cancer | Endometrium Cancer | Vulva Cancer | Squamous Cell Carcinoma, Skin | Anus Cancer

France
Institut de Cancérologie de Lorraine

Terminated

Conversational Hypnosis in Women Undergoing Imaging for Breast Cancer (HYCOREMA)

Breast Cancer

France
Institut de Cancérologie de Lorraine

Completed

Agreement Between Oral and Cervical Human Papillomavirus Infection in a French Cohort (PAPILLOR)

Human Papillomavirus-Related Cervical Carcinoma

France
Institut de Cancérologie de Lorraine

Completed

HE4 as a Relapse Biomarker in Ovarian Cancers (PRONOV4IR)

Ovarian Carcinoma

France
Institut de Cancérologie de Lorraine

Completed

Determination of the Feasibility of Tumoural Somatic Mutations Detection in Blood of Patients With Ovarian Cancer (BOVARY Pilot)

Ovarian Cancer

France
Institut de Cancérologie de Lorraine

Completed

CaptHPV : Validation of the Method "CaptHPV" for the Diagnosis of Human Papillomavirus Associated Infiltrating Carcinomas (CaptHPV)

Cervical Cancer | Vulvar Cancer | Anal Cancer | Oropharynx Cancer | Oral Cavity Cancer | Penis Cancer

France
Institut de Cancérologie de Lorraine

Completed

Detection of KRAS, NRAS et BRAF Mutations in Plasma Circulating DNA From Patients With Metastatic Colorectal Cancer (ColoBEAM)

Colorectal Cancer Metastatic

France
Institut de Cancérologie de Lorraine

Completed

Interest of Self-compression Technique on Tolerance of Mammography (ITACTs)

Breast Cancer

France
Institut de Cancérologie de Lorraine

Completed

Technical Optimization of Detection of KRAS, BRAF and NRAS Mutations on Tumor DNA Circulating in Metastatic Colorectal Cancer (CircuLOR-1)

Metastatic Colorectal Cancer

France
Institut de Cancérologie de Lorraine

Completed

Understanding Low Gynecological Cancer Delay and Help-seeking Behavior in Older Patients. (CODEGY65)

Gynecologic Cancer | Aged | Symptoms and Signs

France
Institut de Cancérologie de Lorraine

Completed

Detection in Peripheral Blood of Circulating Tumor Cells in Patient With Head and Neck Squamous Cell Carcinoma (CTCVADS)

Head and Neck Cancer

France
Institut de Cancérologie de Lorraine

Completed

Prognostic Impact of Programmed Death Ligand-1 Expression in Advanced Endometrial Cancer

Endometrial Cancer
Institut de Cancérologie de Lorraine

Completed

Sarcopenia is an Independent Prognostic Factor for Overall Survival in Patients With Pancreatic Adenocarcinoma

Pancreatic Neoplasms
Institut de Cancérologie de Lorraine

Completed

Intensity-modulated Radiation Therapy From 70Gy to 80Gy in Localized Prostate Cancer

Prostate Cancer
Institut de Cancérologie de la Loire
National Cancer Institute, France

Unknown

I2S-Health Prevention (I2S)

Secondary School Student in General High School Who Does Not Have a Disability That Does Not Allow a Good Understanding of the Study Requirements

United States, France
Institut Cancerologie de l'Ouest
ANSES

Recruiting

Socioeconomic Determinants of the Chemical Exposome and Its Genotoxic Effects in Children (PESTIFOL)

Healthy Volunteer Children

France
Oscar Gerardo Arrieta Rodríguez

Recruiting

Pathogenic Variants in Genes Associated With Lung Adenocarcinoma

Lung Adenocarcinoma

Mexico
Instituto Nacional de Cancerologia de Mexico
National Council of Science and Technology, Mexico

Unknown

Phase II Study of Six Hours Low Dose Gemcitabine Plus Cisplatin in the Treatment for Advanced Pleural Mesothelioma

Advanced Malignant Pleural Mesothelioma

Mexico
Institut Cancerologie de l'Ouest
Esteve

Recruiting

OP2C : Prialt® Observatory in Clinical Practice (OP2C)

Refractory Pain

France
Institut Cancerologie de l'Ouest
ATONCO

Completed

Assessment of safEty, Tolerability, Radiation Dosimetry, and Imaging Properties of 89Zr-labeled giRenTuximab (89Zr-Girentuximab) in patIents With Non-musclE-iNvasive Bladder CancEr (NMIBC) (PERTINENCE)

Bladder Cancer

France
Institut Cancerologie de l'Ouest
AstraZeneca

Active, not recruiting

Prostate Cancer With OligometaSTatic Relapse: Combining Stereotactic Ablative Radiotherapy and Durvalumab (MEDI4736) (POSTCARD)

Bone Metastases | Prostate Cancer Patients | Node; Prostate

France
Instituto Nacional de Cancerologia de Mexico
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

Unknown

Metformin Plus Neoadjuvant Chemotherapy in Breast Cancer

Locally Advanced Malignant Neoplasm

Mexico
National Institute of Cancerología

Recruiting

Evaluation of Concomitant Chemo-radiotherapy With Cisplatine vs Gemcitabin in Locally Advanced Cervicouterine Cancer (MICHELE)

Gemcitabine | Locally Advanced Cervical Cancer | Chemo-radiotherapy

Mexico
National Institute of Cancerología

Recruiting

Validation of the Genetic Signature 354849 as a Prognostic Method

Cervix Cancer

Mexico
National Institute of Cancerología

Recruiting

Chemotherapy and Pelvic Hypofractionated Radiation Followed by Surgery Cervical Cancer

Cervix Cancer

Mexico
National Institute of Cancerología

Active, not recruiting

A Trial Comparing Acute Toxicity in Patients With Gynecological Cancer Treated With VMAT (ATGCRT)

Gynecologic Cancer

Mexico
National Institute of Cancerología

Enrolling by invitation

Effect of Two Cognitive-Behavioral Interventions on Cervical Cancer Patients

Cervical Cancer | Psychological Distress | Coping Skills

Mexico
National Institute of Cancerología

Completed

microRNA Profile in Early-stage Cervical Cancer

Cervical Cancer
National Institute of Cancerología

Unknown

Effect of All-trans Retinoic Acid With Chemotherapy Based on Paclitaxel and Cisplatin As First-line Treatment of Patients With Advanced Non-small Cell Lung Cancer and Expression of RAR-alfa and RAR-beta as Response Biomarker

Non Small Cell Lung Cancer

Mexico
National Institute of Cancerología

Unknown

Concurrent Chemotherapy and Radiotherapy With Nitroglycerin in Patients With Locally Advanced Non-Small Cell Lung Cancer

Locally Advanced Non Small-Cell Lung Canger

Mexico
National Institute of Cancerología

Unknown

DHPLC Determination of TPMT Polymorphisms.

Acute Lymphoblastic Leukemia

Mexico
Instituto Nacional de Cancerologia de Mexico
National Council of Science and Technology, Mexico

Completed

Predictors of Radiation Pneumonitis in Locally Advanced Lung Cancer Treated With Chemoradiation

Radiation; Adverse Effect, Pneumonitis

Mexico
Institut de Cancérologie de la Loire

Completed

Therapeutic Education Intervention in Breast Cancer: PEPs Hormonotherapy (PEPs HORMONO)

Breast Cancer

France
Institut de Cancérologie de la Loire

Completed

Assessment of Human Herpes Virus Reactivation 6 Post Autologous Stem Cells (VIRAUTO6)

Hematologic Diseases

France
Institut de Cancérologie de la Loire

Completed

Risk Factors for Thromboembolic and Infectious Complications Related to Percutaneous Central Venous Catheters in Cancer - Prospective Multicenter Study (ONCOCIP)

Cancer

France
Institut de Cancérologie de la Loire

Completed

Screening for Social Weaknesses and Coordination Course of Cancer Patients (DEFCOCANCERO)

Cancer

France
Institut de Cancérologie de la Loire

Completed

Feasibility Study of an Intervention Therapeutic Education for Patients Treated With Androgen Deprivation (Nutriprophy)

Prostate Cancer

France
Hospital Civil de Guadalajara
Instituto Jalisciense de Cancerologia

Recruiting

The INVADE Study: INnominate Vein Approach for Central Catheterization in Difficult to cannulatE Patients (INVADE)

Critical Illness

Mexico
National Institute of Cancerología
Kimberly-Clark de México

Unknown

Comparison of Iodine + Isopropyl Alcohol Versus Iodine + Antimicrobial Sealant for Skin Preparation

Surgical Site Infection

Mexico
National Institute of Cancerología

Recruiting

Chemotherapy and Pelvic Hypofractionated Radiation Followed by Brachytherapy for Cervical Cancer

Cervical Cancer

Mexico
National Institute of Cancerología

Completed

Factors Associated With Residual Disease In The Central Cone (FARDCC)

Cervical Intraepithelial Neoplasia
National Institute of Cancerología

Unknown

Gene-expression Profiles in CNS-metastatic Non-small Cell Lung Cancer

Lung Cancer | Metastasis | Brain Disease

Mexico
National Institute of Cancerología

Unknown

Therapeutic and Prognostic Impact of Circulating Tumor Cells in Peripheral Blood in Patients With Non Small-cell Lung Cancer

Circulating Tumor Cells

Mexico
National Institute of Cancerología

Unknown

Palliative Treatment With Liposomal Doxorubicin Plus Cisplatin for Patients With Malignant Pleural Mesothelioma

Malignant Pleural Mesothelioma

Mexico
National Institute of Cancerología

Unknown

Diagnostic Accuracy of Fine Needle Aspiration in Parotid Tumors

Parotid Gland Neoplasms

Mexico

Clinical Trials Sponsored by Instituto Nacional de Cancerologia, Columbia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cote d'Ivoire

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations